Lilly’s trial results for treating obesity and pre-diabetes are promising
HQ Team November 15, 2024: Eli Lilly’s Phase III trial has yielded positive results from the SURMOUNT-1 study of tirzepatide (Zepbound and Mounjaro) for.
Health
Drugs
Health
Pharma
Novo Nordisk unveils new drug to fight obesity, says 13% effective
HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.
Drugs
Health
Medical
Parkinson’s drug Ropinirole shows promise as potential treatment for ALS, study finds
HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.